Farallon Capital Management LLC Raises Holdings in Oscar Health, Inc. $OSCR

Farallon Capital Management LLC boosted its holdings in shares of Oscar Health, Inc. (NYSE:OSCR) by 146.5% in the 3rd quarter, Holdings Channel.com reports. The fund owned 3,639,000 shares of the company’s stock after buying an additional 2,163,000 shares during the quarter. Farallon Capital Management LLC’s holdings in Oscar Health were worth $68,886,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of OSCR. Envestnet Asset Management Inc. increased its position in shares of Oscar Health by 200.9% during the 2nd quarter. Envestnet Asset Management Inc. now owns 30,210 shares of the company’s stock worth $648,000 after purchasing an additional 20,171 shares during the last quarter. Udine Wealth Management Inc. lifted its position in Oscar Health by 138.4% in the third quarter. Udine Wealth Management Inc. now owns 146,555 shares of the company’s stock valued at $2,774,000 after buying an additional 85,083 shares during the last quarter. Q Fund Management Hong Kong Ltd acquired a new position in Oscar Health in the third quarter valued at about $5,940,000. Jump Financial LLC boosted its stake in Oscar Health by 798.3% during the second quarter. Jump Financial LLC now owns 1,441,506 shares of the company’s stock worth $30,906,000 after buying an additional 1,281,032 shares during the period. Finally, State of Michigan Retirement System purchased a new position in Oscar Health during the third quarter worth about $27,448,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Wall Street Analysts Forecast Growth

OSCR has been the topic of a number of research analyst reports. Raymond James Financial raised shares of Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 price target on the stock in a research note on Thursday, February 12th. Barclays set a $18.00 price objective on shares of Oscar Health and gave the stock an “equal weight” rating in a research report on Monday, January 5th. UBS Group reissued a “neutral” rating and issued a $15.00 target price on shares of Oscar Health in a research report on Wednesday, February 11th. Piper Sandler upgraded Oscar Health from a “neutral” rating to an “overweight” rating and upped their price target for the stock from $13.00 to $25.00 in a research note on Tuesday, November 25th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a research report on Thursday, January 22nd. Two investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $16.88.

Oscar Health Stock Up 1.7%

Shares of NYSE:OSCR opened at $13.22 on Monday. The firm has a market capitalization of $3.93 billion, a PE ratio of -7.59 and a beta of 1.90. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.80. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.96 and a quick ratio of 0.96. The firm’s 50-day moving average is $14.53 and its two-hundred day moving average is $16.47.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Tuesday, February 10th. The company reported ($1.24) EPS for the quarter, missing the consensus estimate of ($0.92) by ($0.32). The business had revenue of $2.81 billion during the quarter, compared to analysts’ expectations of $3.12 billion. Oscar Health had a negative net margin of 3.79% and a negative return on equity of 39.35%. The company’s revenue for the quarter was up 17.3% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.62) EPS. Analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current year.

Insider Transactions at Oscar Health

In other Oscar Health news, insider Mario Schlosser sold 23,038 shares of the firm’s stock in a transaction that occurred on Thursday, January 8th. The shares were sold at an average price of $17.65, for a total value of $406,620.70. Following the completion of the transaction, the insider owned 350,180 shares of the company’s stock, valued at $6,180,677. This trade represents a 6.17% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. In the last quarter, insiders have sold 138,835 shares of company stock worth $2,298,269. 25.11% of the stock is owned by corporate insiders.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.